Kernal Biologics
Cambridge
About Kernal Biologics
Kernal creates mRNA therapies to cure diseases like COVID and cancer. Our mRNA therapies instruct specific cells on how to make their own drugs. Kernal won three awards from Amgen and NASA. With roots at MIT, Harvard and Big Pharma, the team previously built a successful Biotech company and has deep expertise in mRNA space.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $73.0M
- Funding stage: Early Stage Venture
- Last round: Grant (Oct 2025)
- Website: kernalbio.com
- Phone: +118576000762
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kernal-biologics-8517 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.